(North America, South America, and the Caribbean)
(Including Hong Kong SAR, Macau SAR, and Taiwan)
Target Capture Sequencing (TCS) allows researchers to extract genomic information from exons or regions of interest in the human or mouse genome with customized probes. Novogene’s cost-effective TCS technologies, including Whole Exome Sequencing (WES) and Target Region Sequencing (TRS), deliver much higher coverage than whole genome sequencing for the identification of rare variants and can deliver exceptionable prospects for researchers and patients.
80Gb - 6Tb output range, 1.6 - 40 B paired end reads per run, and PE150, PE250, PE50, etc.
165Gb - 16Tb output range, 3.2 - 52 B paired end reads per run, and PE50, PE100, PE150, etc.c
The field is required.
I agree that Novogene Corporation may use this information to contact me to assist with my request. I understand that all personal information I have submitted will be kept confidential in accordance with Novogene's privacy policy.